CROSS COUNTRY HEALTHCARE INC
Company Information
Industry Services-Help Supply Services
SIC Code 7363
Entity Type operating
SEC Category Accelerated filer
State of Incorporation DE
Business Address 5201 CONGRESS AVENUE, SUITE 160, BOCA RATON, FL,
Mailing Address 5201 CONGRESS AVENUE, SUITE 160, BOCA RATON, FL,
Phone 8003472264
Fiscal Year End 1231
EIN 134066229
Financial Overview
FY2024
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | February 12, 2026 | View on SEC |
| 8-K Current report of material events | January 29, 2026 | View on SEC |
| 4/A Insider transaction amendment | January 12, 2026 | View on SEC |
| 8-K/A Current report amendment | January 2, 2026 | View on SEC |
| 4 Insider stock transaction report | December 22, 2025 | View on SEC |
| 4 Insider stock transaction report | December 22, 2025 | View on SEC |
| 4 Insider stock transaction report | December 22, 2025 | View on SEC |
| 4 Insider stock transaction report | December 22, 2025 | View on SEC |
| 4 Insider stock transaction report | December 22, 2025 | View on SEC |
| 4 Insider stock transaction report | December 22, 2025 | View on SEC |
Material Events
8-K Leadership Change December 15, 2025
High Impact
- John A. Martins has departed as President and CEO of Cross Country Healthcare.
- Kevin C. Clark, co-founder and Chairman, has returned as President and CEO.
Insider Trading
BUY 1 insiders
2 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 7363)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.